Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
GMAB

Market Cap: $18.31B

GA

Genmab A/S

GMAB

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin38.74%

EBITDA Margin14.98%

EBIT Margin14.69%

Pre-tax Margin10.99%

Net Profit Margin8.72%

Earnings Yield4.57%

Valuation Multiples

Price / Book3.16

Price / Sales1.91

Price / Earnings22.00

PEG-0.25

Forward PEG0.45

EV / Sales2.31

EV / EBITDA15.45

EV / Operating Cash Flow24.10

EV / Free Cash Flow24.94

Price / Free Cash Flow20.55

Price / Operating Cash Flow19.86

Cash Flow & Capital

Free Cash Flow / Share$1.42

Operating Cash Flow / Share$1.47

Free Cash Flow Yield4.87%

Capex / Revenue0.32%

Capex / Operating Cash Flow3.34%

Capex / Depreciation0.36

Stock Compensation / Revenue1.61%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.18

Quick Ratio2.17

Cash Ratio1.29

Debt / Assets0.43

Debt / Capital0.49

Debt / Equity0.94

Long-Term Debt / Capital0.46

Debt / Market Cap29.10%

Net Debt / EBITDA2.72

Solvency Ratio0.14

Financial Leverage2.18

Efficiency & Working Capital

Asset Turnover0.76

Fixed Asset Turnover35.56

Inventory Turnover12.47

Receivables Turnover9.14

Payables Turnover0.30

Days Sales Outstanding39.94

Days Inventory Outstanding29.28

Days Payables Outstanding1,200.43

Operating Cycle69.22

Cash Conversion Cycle-1,131.21

Working Capital Turnover6.61

Returns & Quality

Return on Equity14.55%

Return on Assets6.64%

Return on Invested Capital8.89%

ROCE11.49%

Return on Tangible Assets26.75%

Operating Return on Assets10.19%

Income Quality0.91

Tax Burden0.79

Interest Burden0.75

Balance Sheet & Intrinsic Metrics

Enterprise Value$21.79B

Invested Capital$10.95B

Working Capital$1.39B

Tangible Asset Value$-3.62B

Net Current Asset Value$-4.12B

Graham Number$166.83

Graham Net-Net-$7.14

Book Value / Share$9.25

Tangible Book Value / Share-$5.89

Cash / Share$2.48

Financial Health Scores

Piotroski Score6

Altman Z-Score11.61

Revenue$3.9B

EBIT$1.2B

Market Cap$115.71B

Working Capital$1.39B

Retained Earnings$4.09B

Total Assets$12.38B

Total Liabilities$6.69B